JAVIER
ANGULO CUESTA
CATEDRÁTICO
Hospital de Cruces
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Cruces (31)
2024
-
The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy
International Journal of Molecular Sciences, Vol. 25, Núm. 3
2022
-
Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level
Current Urology Reports, Vol. 23, Núm. 6, pp. 93-97
-
Urological Cancer Panorama in the Second Year of the COVID-19 Pandemic
Cancers
2021
-
(Pro)renin receptor is a novel independent prognostic marker in invasive urothelial carcinoma of the bladder
Cancers, Vol. 13, Núm. 22
-
Clinical implications of (Pro)renin receptor (prr) expression in renal tumours
Diagnostics, Vol. 11, Núm. 2
-
Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma
Cancers, Vol. 13, Núm. 4, pp. 1-17
-
The role of epigenetics in the progression of clear cell renal cell carcinoma and the basis for future epigenetic treatments
Cancers, Vol. 13, Núm. 9
2020
-
Altered tissue and plasma levels of fibroblast activation protein-α (FAP) in renal tumours
Cancers, Vol. 12, Núm. 11, pp. 1-16
2019
-
A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma
Current Urology Reports, Vol. 20, Núm. 1
-
Precise definition of PTEN C-terminal epitopes and its implications in clinical oncology
npj Precision Oncology, Vol. 3, Núm. 1
-
Precise immunodetection of PTEN protein in human neoplasia
Cold Spring Harbor Perspectives in Medicine, Vol. 9, Núm. 12
-
The coexpression of fibroblast activation protein (FAP) and basal-type markers (CK 5/6 and CD44) predicts prognosis in high-grade invasive urothelial carcinoma of the bladder
Human Pathology, Vol. 91, pp. 61-68
2018
-
High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 27-30
-
Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma
Annals of Diagnostic Pathology, Vol. 34, pp. 89-93
-
Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy
Pathology Research and Practice, Vol. 214, Núm. 8, pp. 1110-1114
2017
-
CD34 immunostaining enhances a distinct pattern of intratumor angiogenesis with prognostic implications in clear cell renal cell carcinoma
APMIS, Vol. 125, Núm. 2, pp. 128-133
2016
-
A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy
Urologia Internationalis, Vol. 97, Núm. 1, pp. 16-25
-
DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects
Molecular Diagnosis and Therapy, Vol. 20, Núm. 6, pp. 531-549
-
Desvelando el proceso de producción de Les Tumeurs de la Vessie de Joaquín Albarrán 125 años después de su escritura
Actas Urologicas Espanolas, Vol. 40, Núm. 7, pp. 463-469
-
Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile
Journal of Urology, Vol. 195, Núm. 3, pp. 619-626